Aleafia Health Provides Corporate By-law Update
May 06 2019 - 5:16PM
Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH)
(“
Aleafia Health” or the
“
Company”) Board of Directors have approved an
advance notice by‑law, the purpose of which is to require that
advance notice be provided to the Company in circumstances in which
nominations of persons for election to the Board are made by
shareholders other than pursuant to the requisition of a meeting or
a shareholder proposal in accordance with the Business Corporations
Act (Ontario) (the “
Advance Notice By-law”).
The Advance Notice By‑law fixes a deadline by
which shareholders must provide notice to the Company of
nominations for election to the Board, and sets out the information
that a shareholder must include in the notice for it to be
valid.
In the case of an annual meeting of
shareholders, the notice must be delivered to the Company no fewer
than 30 days prior to the date of the meeting (except that, if the
meeting is to be held on a date that is fewer than 50 days after
the first public filing or announcement of the date of the meeting,
the notice must be delivered no more than 10 days after the date of
that public filing or announcement).
In the case of a special meeting of shareholders
(which is not also an annual meeting), the notice must be delivered
to the Company no more than 15 days after the date of the first
public filing or announcement of the date of the meeting.
However, in respect only of the Company’s
upcoming annual and special meeting of shareholders to be held on
June 17, 2019, the 30-day notice requirement has been waived by the
Board and instead the Board has determined that notice must be
delivered to the Company by no later than 5:00 p.m. EDT on May 27,
2019.
“The approval of the advance notice by‑law aims
to ensure that an orderly nomination process is observed, that
shareholders are well-informed about director nominees and that
shareholders are able to vote in an informed manner after having
been afforded reasonable time for appropriate deliberation,” said
Aleafia Health Chairman Julian Fantino.
The Advance Notice By‑law is effective
immediately. In accordance with the Business Corporations Act
(Ontario), the Advance Notice By-law will be submitted to the
shareholders for confirmation at the Company’s upcoming shareholder
meeting.
The Advance Notice By-law is being filed under
the Company’s profile on SEDAR at www.sedar.com and will be
available at www.aleafiahealth.com/investors/ under the heading
“Corporate Governance Materials”.
For Investor and Media Relations, please
contact:
Nicholas Bergamini, VP, Public
Affairs416-860-5665IR@AleafiaHealth.comLEARN MORE:
www.AleafiaHealth.com
About Aleafia Health:
Aleafia Health is a leading, vertically
integrated cannabis health and wellness company with four primary
business units: Cannabis Cultivation & Products, Health &
Wellness Clinics, Cannabis Education, and Consumer Experience with
ecommerce, retail distribution and provincial supply
agreements.
Aleafia Health owns three major cannabis product
& cultivation facilities, two of which are licensed and
operational. The Company produces a diverse portfolio of
commercially proven, high-margin derivative products including
oils, capsules and sprays. Aleafia Health operates the largest
national network of medical cannabis clinics and education centres
staffed by MDs, nurse practitioners and educators.
Aleafia Health maintains a medical cannabis
dataset with over 10 million data points to inform proprietary
illness specific product development and treatment best practices.
The Company is committed to creating sustainable shareholder value
and has been named the 2019 top performing company of the year by
the TSX Venture Exchange before it graduated to the TSX.
Forward Looking Information
This news release contains “forward-looking
information” within the meaning of applicable Canadian securities
laws, including statements regarding the Company’s upcoming
shareholder meeting. Forward-looking information is not a guarantee
of future performance, given that it involves risks and
uncertainties. Except as required by law, the Company does not
assume and expressly renounces any obligation to update any
forward-looking information, which is only applicable on the date
on which it is given.